Cannaus
  • Home
  • State News
    • ACT
    • QLD
    • NSW
    • NT
    • SA
    • TAS
    • VIC
    • WA
  • Topics
    • Business
    • CBD
    • Government
    • Hemp
    • International
    • Legalisation
    • Medicinal Cannabis
    • Offences
    • Research
    • Misc
  • Cannabis Companies
No Result
View All Result
Cannaus

Epsilon Healthcare (ASX: EPN) opens factory door to Canadian cannabis company Valens in new deal

4 years ago
in National
0
Green cannabis plant

Green cannabis plant

Share on FacebookShare on Twitter

Epsilon Healthcare (ASX: EPN), formerly known as THC Global, has announced a new partnership with Canadian medical cannabis company The Valens Company (TSX: VLNS). 

Epsilon will give Valens access to its expertise and Queensland-based medical cannabis extraction plant as part of the new deal. The extraction plant is the largest of its kind in the southern hemisphere. It currently produces cannabis medicines that are compliant with Australian regulations and the European Union’s GMP guidelines. You can find it one hour from Brisbane in Southport.

Together, Valens and Epsilon will produce medicines that they will sell in Australia and New Zealand under the Valens Australia Pty Ltd label. Valens Australia is a subsidiary company of Valens. 

Epsilon Healthcare and The Valens Company

Valens will take over the Southport facility, though Epsilon will continue to supply staff and support. Valens will also pay for the operation of the Southport cannabis extraction plant as long as the partnership lasts. In exchange, they will have access to up to 85% of the manufacturing output for the next five years (with the option to extend the deal for six years after that). 

Valens new medicines will be distributed by Cannvalate. The medicines will reach medical cannabis patients reasonably quickly, as the first products in the partnership will be delivered in the next few weeks. However, the two companies also have the capacity to sell the medicines in the UK, Europe, the Asia-Pacific region, and Latin America in the future.  

According to Valens CEO Tyler Robson, the deal will help Valens enter Australia’s medical cannabis market quickly. 

We believe this strategic partnership is an efficient use of capital towards accessing GMP quality products and accelerates our timeline to market dramatically.

In related news, Epsilon has also announced that they purchased Cannvalate’s subsidiary AlternaMed for $4.3 million. As part of the deal, Cannvalate put a director on Epsilon’s board, and Epsilon will issue Cannvalate 28 million shares (though Cannvalate already holds 2 million shares in Epsilon).

Tags: Business
Share9Tweet6
Karie Cornell

Karie Cornell

Based in Victoria, Karie's passionate about pro-cannabis legislation in Australia. She joined Cannaus to share and bring awareness to the latest cannabis news across Australia.

Related Posts

Cannabis leaf with seeds
National

WA government classifies a cannabis seed the same as a fully-grown plant

January 13, 2022
Small cannabis plant growing in a pot
National

New Zealand-based cannabis producer Greenfern reaches partnership agreement with Cannvalate

January 13, 2022
Cannabis medicine
National

Study shows the majority of women using medical cannabis for endometriosis obtain it illegally

January 11, 2022
Green cannabis leaf on wood
National

Cannim set to become major name in adult-use cannabis market through strategic merger

December 27, 2021
Cannabis oil with bud
National

Elixinol Wellness (ASX: EXL) signs deal with major British cannabis company

December 27, 2021
Penalty
National

TGA fines St Francis Pharmacy nearly $40k for advertising medicinal cannabis

December 23, 2021
Subscribe
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments
Weekly Cannabis News

Get the latest Australian cannabis news straight to your inbox every week.

Enter your email address
  • Home
  • Contact
  • Privacy Policy

Disclaimer
Cannaus does not recommend that anyone uses cannabis for medical or adult use purposes unless consulted by a medical professional. Cannabis is a drug and may have negative side effects. Please consult with your doctor to find out if cannabis is right for you.

  • Home
  • State News
    • ACT
    • QLD
    • NSW
    • NT
    • SA
    • TAS
    • VIC
    • WA
  • Topics
    • Business
    • CBD
    • Government
    • Hemp
    • International
    • Legalisation
    • Medicinal Cannabis
    • Offences
    • Research
    • Misc
  • Cannabis Companies
No Result
View All Result
Weekly Cannabis News

Get the latest Australian cannabis news straight to your inbox every week.

Enter your email address

Thanks, I’m not interested

wpDiscuz